A. Balogh

发表

The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology/RTOG 0534 SPPORT): an international, multicentre, randomised phase 3 trial

D. Low, H. Sandler, G. Rodrigues, 2022, The Lancet.

Management of small cell carcinoma of the bladder: Consensus guidelines from the Canadian Association of Genitourinary Medical Oncologists (CAGMO).

P. Black, A. Eisen, I. Cagiannos, 2013, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials

R. Socher, James Y. Zou, S. Yeung, 2022, npj Digital Medicine.

Double high-dose therapy with dose-intensive cyclophosphamide, etoposide, cisplatin (DICEP) followed by high-dose melphalan and autologous stem cell transplantation for relapsed/refractory Hodgkin lymphoma

P. Duggan, D. Stewart, J. Russell, 2012, Leukemia & lymphoma.

Definitive radiotherapy for localized follicular lymphoma staged by 18F-FDG PET-CT: a collaborative study by ILROG.

H. Eich, A. Ng, L. Constine, 2019, Blood.

Biochemical Failure Is Not a Surrogate End Point for Overall Survival in Recurrent Prostate Cancer: Analysis of NRG Oncology/RTOG 9601

A. Zietman, H. Sandler, R. Dess, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

In pursuit of an artful death: discussion of resuscitation status on an inpatient radiation oncology service

A. Fairchild, K.-L. Kelly, A. Balogh, 2005, Supportive Care in Cancer.

Salvage Treatment and Survival for Relapsed Follicular Lymphoma Following Primary Radiation Therapy: A Collaborative Study on Behalf of ILROG.

H. Eich, A. Ng, L. Constine, 2019, International journal of radiation oncology, biology, physics.

Allogeneic transplantation for adult acute leukemia in first and second remission with a novel regimen incorporating daily intravenous busulfan, fludarabine, 400 CGY total-body irradiation, and thymoglobulin.

J. Storek, N. Bahlis, N. Bahlis, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A phase III protocol of androgen suppression (AS) and 3DCRT/IMRT versus AS and 3DCRT/IMRT followed by chemotherapy (CT) with docetaxel and prednisone for localized, high-risk prostate cancer (RTOG 0521).

R. Hannan, J. Purdy, M. Amin, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Transplantation from matched siblings using once-daily intravenous busulfan/fludarabine with thymoglobulin: a myeloablative regimen with low nonrelapse mortality in all but older patients with high-risk disease.

J. Storek, P. Duggan, N. Bahlis, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

NRG Oncology/RTOG 9601, a phase III trial in prostate cancer patients: Anti-androgen therapy (AAT) with bicalutamide during and after salvage radiation therapy (RT) following radical prostatectomy (RP) and an elevated PSA.

D. Grignon, A. Zietman, H. Sandler, 2016 .

Short Term Androgen Deprivation Therapy Without or With Pelvic Lymph Node Treatment Added to Prostate Bed Only Salvage Radiotherapy: The NRG Oncology/RTOG 0534 SPPORT Trial

D. Low, H. Sandler, É. Vigneault, 2018, International Journal of Radiation Oncology*Biology*Physics.

MP72-01 IMPROVEMENTS IN FREEDOM FROM PROGRESSION WITH SHORT TERM ANDROGEN DEPRIVATION THERAPY AND PELVIC LYMPH NODE TREATMENT ADDED TO PROSTATE BED SALVAGE RADIOTHERAPY: THE NRG ONCOLOGY/RTOG 0534 SPPORT TRIAL

D. Low, H. Sandler, J. Michalski, 2019, Journal of Urology.

The addition of 400 cGY total body irradiation to a regimen incorporating once-daily intravenous busulfan, fludarabine, and antithymocyte globulin reduces relapse without affecting nonrelapse mortality in acute myelogenous leukemia.

W. Irish, J. Storek, P. Duggan, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Effect of Chemotherapy With Docetaxel With Androgen Suppression and Radiotherapy for Localized High-Risk Prostate Cancer: The Randomized Phase III NRG Oncology RTOG 0521 Trial.

R. Hannan, H. Sandler, J. Purdy, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer

D. Grignon, A. Zietman, H. Sandler, 2017, The New England journal of medicine.

Duration of androgen suppression before radiotherapy for localized prostate cancer: radiation therapy oncology group randomized clinical trial 9910.

H. Sandler, M. Amin, T. Pisansky, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Stage I-II Nodular Lymphocyte-Predominant Hodgkin Lymphoma: a Multi-institutional Experience of Adult Patients by ILROG.

H. Eich, Y. Natkunam, R. Advani, 2020, Blood.

A quality review of the occurrence of a non-fatal venous air embolism event following CT contrast enhanced administration for the purpose of radiation therapy planning

P. Burrowes, G. Brunet, A. Balogh, 2013, Journal of Radiotherapy in Practice.

Serum testosterone changes in patients treated with radiation therapy alone for prostate cancer on NRG oncology RTOG 9408

Christopher U. Jones, H. Sandler, A. Raben, 2017, Advances in radiation oncology.

Acute and late urinary toxicity following radiation in men with an intact prostate gland or after a radical prostatectomy: A secondary analysis of RTOG 94-08 and 96-01.

Christopher U. Jones, R. Mak, H. Sandler, 2016, Urologic oncology.

Adjuvant docetaxel for high-risk localized prostate cancer: Update of NRG Oncology/RTOG 0521.

Christopher U. Jones, R. Hannan, H. Sandler, 2020 .

Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials

R. Socher, James Y. Zou, M. Lungren, 2022, npj Digital Medicine.

Clinical Outcomes from Dose-Reduced Radiotherapy to the Prostate in Elderly Patients with Localized Prostate Cancer

M. Roumeliotis, S. Husain, S. Quirk, 2021, Current oncology.

Extended SSD VMAT treatment for total body irradiation

A. Hudson, A. Balogh, G. Pierce, 2018, Journal of applied clinical medical physics.

Androgen Deprivation and Radiotherapy with or Without Docetaxel for Localized High-risk Prostate Cancer: Long-term Follow-up from the Randomized NRG Oncology RTOG 0521 Trial.

Christopher U. Jones, R. Hannan, H. Sandler, 2023, European urology.

Electronic compensation using multileaf collimation for involved field radiation to the neck and mediastinum in non-Hodgkin's lymphoma and Hodgkin's lymphoma.

S. Sawchuk, D. Spencer, A. Balogh, 2005, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

Report of NRG Oncology/RTOG 9601, A Phase 3 Trial in Prostate Cancer: Anti-androgen Therapy (AAT) With Bicalutamide During and After Radiation Therapy (RT) in Patients Following Radical Prostatectomy (RP) With pT2-3pN0 Disease and an Elevated PSA

D. Grignon, A. Zietman, H. Sandler, 2016 .

225 Total scalp irradiation using intensity modulated radiotherapy for scalp lymphoma

K. Rans, A. Balogh, A. Pearce, 2005 .

Management of small cell carcinoma of the bladder: Consensus guidelines from the Canadian Association of Genitourinary Medical Oncologists (CAGMO).

P. Black, A. Eisen, I. Cagiannos, 2013, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

J. Storek, P. Duggan, N. Bahlis, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

W. Irish, C. Brown, J. Storek, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Standardized flattening filter free volumetric modulated arc therapy plans based on anteroposterior width for total body irradiation

Jeffrey Q. Cao, A. Hudson, A. Balogh, 2020, Journal of applied clinical medical physics.